Loading
·
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.